Effectiveness of Inactivated COVID-19 Vaccine of the First Booster Dose
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- André Machado amsiqueira@gmail.com, Doctor
amsiqueira@gmail.com
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Instituto Nacional de Infectologia Evandro Chagas (ini-Fiocruz)
Manguinhos, Brazil
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jul 2022
- Primary completion
- 15 Aug 2022
- Completion
- 15 Feb 2023
- Last update posted
- 12 Jan 2023
- Registered enrollment
- 14,000
- Registry id
- NCT05367895
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.